This could raise the risk of gallbladder disease
Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Bambini, donne incinte o allattanti consultare il medico prima delluso
These considerations reinforce the importance of patient selection, dosing strategy, and ongoing monitoring
If the redness extends beyond 5 centimeters from the site, persists for more than a few days, or is accompanied by warmth or pus, this could indicate an infection rather than a reaction
Norwood-Hamilton Scale The standard classification system for male pattern baldness, ranging from Type I (no significant loss) to Type VII (extensive loss)